Back to search
FDAFDA · Food and drugs·Recall number D-0283-2019

Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31

Published November 28, 2018 · Recall initiated: November 7, 2018

Summary

FDA records drug Class II recall D-0283-2019, published November 28, 2018 and initiated November 7, 2018. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 4,212 (30-count blister pack); Lot: Lot #: T600530, Exp 11/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if CLOPIDOGREL BISULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CLOPIDOGREL BISULFATE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
U.S.A.nationwide
Lot
Lot #: T600530, Exp 11/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31 recalled?

Yes. FDA published recall D-0283-2019 on November 28, 2018. Reported hazard: Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CLOPIDOGREL BISULFATE.